MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons
Neuron · 2024-06 · 112 (12) · 1943-1958.e10
DOI: 10.1016/j.neuron.2024.04.007 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neuron, 2024-06. Verfasst von Yi Liu und 14 weiteren Autor:innen. Beteiligte Einrichtung: Whitehead Institute for Biomedical Research, Cambridge, MA 02142, USA. Hauptthemen laut MEDLINE: RNA Polymerase II, Methyl-CpG-Binding Protein 2, Neurons, Transcription, Genetic. Die Arbeit wurde bisher 71-mal zitiert (Crossref) und nennt 93 Literaturangaben. Gefördert von: NIH HHS, The Owens Family Foundation, Howard Hughes Medical Institute.
Abstract (Originalsprache)
Mutations in the methyl-DNA-binding protein MECP2 cause the neurodevelopmental disorder Rett syndrome (RTT). How MECP2 contributes to transcriptional regulation in normal and disease states is unresolved; it has been reported to be an activator and a repressor. We describe here the first integrated CUT&Tag, transcriptome, and proteome analyses using human neurons with wild-type (WT) and mutant MECP2 molecules. MECP2 occupies CpG-rich promoter-proximal regions in over four thousand genes in human neurons, including a plethora of autism risk genes, together with RNA polymerase II (RNA Pol II). MECP2 directly interacts with RNA Pol II, and genes occupied by both proteins showed reduced expression in neurons with MECP2 patient mutations. We conclude that MECP2 acts as a positive cofactor for RNA Pol II gene expression at many neuronal genes that harbor CpG islands in promoter-proximal regions and that RTT is due, in part, to the loss of gene activity of these genes in neurons.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Whitehead Institute for Biomedical Research, Cambridge, MA 02142, USA.
- Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02142, USA.
- Department of Physiology and Cellular Biophysics, Columbia University Medical Center, New York, NY 10032, USA.
- Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02142, USA; Howard Hughes Medical Institute, Massachusetts Institute of Technology, Cambridge, MA 02142, USA.
- Whitehead Institute for Biomedical Research, Cambridge, MA 02142, USA; Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02142, USA.
- Whitehead Institute for Biomedical Research, Cambridge, MA 02142, USA; Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02142, USA. Electronic address: jaenisch@wi.mit.edu.
Förderung
- NIH HHS
- The Owens Family Foundation
- Howard Hughes Medical Institute
- NIH
- Canadian Institutes of Health Research
- International Rett Syndrome Foundation
Zitieren
APA
Liu, Y., Flamier, A., Bell, G. W., Diao, A. J., Whitfield, T. W., Wang, H. C., Wu, Y., Schulte, F., Friesen, M., Guo, R., Mitalipova, M., Liu, X. S., Vos, S. M., Young, R. A., & Jaenisch, R. (2024). MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. Neuron, 112(12), 1943-1958.e10. https://doi.org/10.1016/j.neuron.2024.04.007
Vancouver
Liu Y, Flamier A, Bell GW, Diao AJ, Whitfield TW, Wang HC, et al. MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. Neuron. 2024;112(12):1943-1958.e10. doi:10.1016/j.neuron.2024.04.007
BibTeX
@article{Liu2024,
author = {Liu, Yi and Flamier, Anthony and Bell, George W and Diao, Annette Jun and Whitfield, Troy W and Wang, Hao-Che and Wu, Yizhe and Schulte, Fabian and Friesen, Max and Guo, Ruisi and Mitalipova, Maisam and Liu, X Shawn and Vos, Seychelle M and Young, Richard A and Jaenisch, Rudolf},
title = {MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons},
journal = {Neuron},
year = {2024},
volume = {112},
number = {12},
pages = {1943--1958.e10},
doi = {10.1016/j.neuron.2024.04.007}
}
EUVIMED